Compounds > edaravone
Page last updated: 2024-10-30

edaravone and Leukemia, T-Cell

edaravone has been researched along with Leukemia, T-Cell in 2 studies

Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.

Research Excerpts

ExcerptRelevanceReference
"Edaravone has been reported to have a radioprotective effect at high concentrations."1.36Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations. ( Enomoto, A; Hosoi, Y; Igaki, H; Katsumura, Y; Matsumoto, Y; Miyagawa, K; Morita, A; Nakagawa, K; Sasano, N; Shiraishi, K, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasano, N2
Enomoto, A2
Hosoi, Y2
Katsumura, Y2
Matsumoto, Y2
Morita, A1
Shiraishi, K2
Miyagawa, K2
Igaki, H2
Nakagawa, K2

Other Studies

2 other studies available for edaravone and Leukemia, T-Cell

ArticleYear
Edaravone, a known free radical scavenger, enhances X-ray-induced apoptosis at low concentrations.
    Cancer letters, 2010, Jul-01, Volume: 293, Issue:1

    Topics: Antipyrine; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Edaravone; Free Radical S

2010
Free radical scavenger edaravone suppresses x-ray-induced apoptosis through p53 inhibition in MOLT-4 cells.
    Journal of radiation research, 2007, Volume: 48, Issue:6

    Topics: Antipyrine; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Dose-Response Relationshi

2007